Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
In scientific literature, tirzepatide is recognized as a first-in-class dual incretin receptor agonist designed to harness the complementary effects of both incretin hormones while incorporating structural modifications (fatty acid moiety) that extend its half-life through albumin binding
Combination approaches targeting multiple pathways show promise
However, it may not be suitable for individuals with active cancer or severe health conditions
The prescribing information for tirzepatide states that available data are inadequate to determine a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes
Boosted Immune Function: Aids in fighting infections and diseases by supporting the function of immune cells
Environmental stressors like air pollution, sunlight, and even the mental stress of a workday can increase free radical production
US$ 23.00
US$ 26.23
US$ 25.80
US$ 28.32
US$ 26.41
